253 related articles for article (PubMed ID: 33911281)
1. C. difficile exploits a host metabolite produced during toxin-mediated disease.
Pruss KM; Sonnenburg JL
Nature; 2021 May; 593(7858):261-265. PubMed ID: 33911281
[TBL] [Abstract][Full Text] [Related]
2. Clostridioides difficile exploits toxin-mediated inflammation to alter the host nutritional landscape and exclude competitors from the gut microbiota.
Fletcher JR; Pike CM; Parsons RJ; Rivera AJ; Foley MH; McLaren MR; Montgomery SA; Theriot CM
Nat Commun; 2021 Jan; 12(1):462. PubMed ID: 33469019
[TBL] [Abstract][Full Text] [Related]
3. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
4. The role of toxin A and toxin B in Clostridium difficile infection.
Kuehne SA; Cartman ST; Heap JT; Kelly ML; Cockayne A; Minton NP
Nature; 2010 Oct; 467(7316):711-3. PubMed ID: 20844489
[TBL] [Abstract][Full Text] [Related]
5. Heme sensing and detoxification by HatRT contributes to pathogenesis during Clostridium difficile infection.
Knippel RJ; Zackular JP; Moore JL; Celis AI; Weiss A; Washington MK; DuBois JL; Caprioli RM; Skaar EP
PLoS Pathog; 2018 Dec; 14(12):e1007486. PubMed ID: 30576368
[TBL] [Abstract][Full Text] [Related]
6. Functional analyses of epidemic Clostridioides difficile toxin B variants reveal their divergence in utilizing receptors and inducing pathology.
Pan Z; Zhang Y; Luo J; Li D; Zhou Y; He L; Yang Q; Dong M; Tao L
PLoS Pathog; 2021 Jan; 17(1):e1009197. PubMed ID: 33507919
[TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile toxins: mediators of inflammation.
Shen A
J Innate Immun; 2012; 4(2):149-58. PubMed ID: 22237401
[TBL] [Abstract][Full Text] [Related]
8. Glucosylation Drives the Innate Inflammatory Response to Clostridium difficile Toxin A.
Cowardin CA; Jackman BM; Noor Z; Burgess SL; Feig AL; Petri WA
Infect Immun; 2016 Aug; 84(8):2317-2323. PubMed ID: 27271747
[TBL] [Abstract][Full Text] [Related]
9. Medical microbiology: A toxin contest.
Ballard JD
Nature; 2010 Oct; 467(7316):665-6. PubMed ID: 20930831
[No Abstract] [Full Text] [Related]
10. Rho factor mediates flagellum and toxin phase variation and impacts virulence in Clostridioides difficile.
Trzilova D; Anjuwon-Foster BR; Torres Rivera D; Tamayo R
PLoS Pathog; 2020 Aug; 16(8):e1008708. PubMed ID: 32785266
[TBL] [Abstract][Full Text] [Related]
11. Clostridium difficile infection: toxins and non-toxin virulence factors, and their contributions to disease establishment and host response.
Vedantam G; Clark A; Chu M; McQuade R; Mallozzi M; Viswanathan VK
Gut Microbes; 2012; 3(2):121-34. PubMed ID: 22555464
[TBL] [Abstract][Full Text] [Related]
12. Both, toxin A and toxin B, are important in Clostridium difficile infection.
Kuehne SA; Cartman ST; Minton NP
Gut Microbes; 2011; 2(4):252-5. PubMed ID: 21804353
[TBL] [Abstract][Full Text] [Related]
13. Toxin B is essential for virulence of Clostridium difficile.
Lyras D; O'Connor JR; Howarth PM; Sambol SP; Carter GP; Phumoonna T; Poon R; Adams V; Vedantam G; Johnson S; Gerding DN; Rood JI
Nature; 2009 Apr; 458(7242):1176-9. PubMed ID: 19252482
[TBL] [Abstract][Full Text] [Related]
14. The Clostridium difficile spo0A gene is a persistence and transmission factor.
Deakin LJ; Clare S; Fagan RP; Dawson LF; Pickard DJ; West MR; Wren BW; Fairweather NF; Dougan G; Lawley TD
Infect Immun; 2012 Aug; 80(8):2704-11. PubMed ID: 22615253
[TBL] [Abstract][Full Text] [Related]
15. The role of flagella in Clostridium difficile pathogenicity.
Stevenson E; Minton NP; Kuehne SA
Trends Microbiol; 2015 May; 23(5):275-82. PubMed ID: 25659185
[TBL] [Abstract][Full Text] [Related]
16. A new role for heat shock factor 27 in the pathophysiology of
Yanda MK; Guggino WB; Cebotaru L
Am J Physiol Gastrointest Liver Physiol; 2020 Jan; 318(1):G120-G129. PubMed ID: 31709831
[No Abstract] [Full Text] [Related]
17.
Furtado KL; Plott L; Markovetz M; Powers D; Wang H; Hill DB; Papin J; Allbritton NL; Tamayo R
mSphere; 2024 Jun; 9(6):e0008124. PubMed ID: 38837404
[TBL] [Abstract][Full Text] [Related]
18. Detection and elimination of a novel non-toxigenic
Maslanka JR; Gu CH; Zarin I; Denny JE; Broadaway S; Fett B; Mattei LM; Walk ST; Abt MC
Gut Microbes; 2020 Nov; 12(1):1-15. PubMed ID: 33305657
[No Abstract] [Full Text] [Related]
19. Clostridioides difficile Toxin A Remodels Membranes and Mediates DNA Entry Into Cells to Activate Toll-Like Receptor 9 Signaling.
Chen X; Yang X; de Anda J; Huang J; Li D; Xu H; Shields KS; Džunková M; Hansen J; Patel IJ; Yee EU; Golenbock DT; Grant MA; Wong GCL; Kelly CP
Gastroenterology; 2020 Dec; 159(6):2181-2192.e1. PubMed ID: 32841647
[TBL] [Abstract][Full Text] [Related]
20. ZupT Facilitates Clostridioides difficile Resistance to Host-Mediated Nutritional Immunity.
Zackular JP; Knippel RJ; Lopez CA; Beavers WN; Maxwell CN; Chazin WJ; Skaar EP
mSphere; 2020 Mar; 5(2):. PubMed ID: 32161145
[No Abstract] [Full Text] [Related]
[Next] [New Search]
